Fig. 6From: Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy(a) Comparison of the combi-3 for drug-resistant EV markers between patients with breast cancer who responded to NAC and patients with breast cancer who were resistant to NAC. The top graph represents patients with TNBC (n = 20) and the lower graph represents patients with all subtypes (n = 36). Statistical analysis was performed using the Welch’s t-test. (b) ROC curves for the three drug-resistant EV markers and the combination markerBack to article page